Market News & Trends
Thermo Fisher Scientific & NIBRT Announce Scientific Collaboration
Thermo Fisher Scientific and the National Institute for Bioprocessing Research and Training (NIBRT) recently announced a scientific collaboration focused on the development of analytical solutions…
Pluristem Reports Data Showing PLX-PAD Cells Effective in Treating Duchenne Muscular Dystrophy
Pluristem Therapeutics Inc. recently reported positive data from preclinical studies of its PLX-PAD cells in the treatment of Duchenne muscular dystrophy. The studies were conducted…
ERT Develops Industry’s First Integration of Continuous Glucose Monitoring Data & eCOA
ERT, a leading provider of high-quality patient data collection solutions for use in clinical drug development, recently announced a data license agreement with Dexcom to…
Cobra Biologics & Alligator Bioscience Extend Drug Development Partnership
Cobra Biologics has recently been contracted to develop a second cell line for Alligator Bioscience AB. Alligator has requested further support from the team at…
Co-Processed Excipients Benefit Market, Offer Opportunity
The excipients market is pharmaceutical manufacturing dependent, and the demand for excipients is constantly changing according to the production needs of manufacturers’ business strategies, marketing…
Hearty CAGRs for Global Cardiac Biomarker Market
The global cardiac biomarker market should see excellent growth rates among major regions due to the growing prevalence and incidence rates of cardiac diseases. BCC…
Co-Processed Excipients Benefit Market, Offer Opportunity
The excipients market is pharmaceutical manufacturing dependent, and the demand for excipients is constantly changing according to the production needs of manufacturers’ business strategies, marketing…
Hearty CAGRs for Global Cardiac Biomarker Market
The global cardiac biomarker market should see excellent growth rates among major regions due to the growing prevalence and incidence rates of cardiac diseases. BCC…
Sekisui XenoTech Introduces New Research BioBank
Sekisui XenoTech Introduces New Research BioBank As part of Sekisui XenoTech’s commitment to furthering knowledge of hepatic diseases, the company has begun providing disease-diagnosed tissue…
Sagent Pharmaceuticals Acquires Product Portfolio
Sagent Pharmaceuticals, Inc. recently announced it has entered into a definitive agreement with Teva Pharmaceutical Industries Ltd. (Teva) and Actavis LLC to acquire a portfolio…
Crown Bioscience Announces Strengthening of Global Immuno-Oncology Platform
Crown Bioscience recently announced the strengthening of its global Immuno-Oncology Platform at all its key facilities in Europe, US, and Asia to support client’s needs…
Argos Therapeutics Enters Strategic Research Agreement With Adaptive Biotechnologies
Argos Therapeutics, Inc. recently announced that it is partnering with Adaptive Biotechnologies Corporation, based in Seattle, WA, to study precise response patterns to Argos’ investigational…
Aegerion Pharmaceuticals & QLT Agree to Strategic Merger
Aegerion Pharmaceuticals, Inc. and QLT Inc. recently announced they have entered into a definitive merger agreement under which Aegerion will be merged with a wholly…
Pharmaceutical Industry Licensing Deals Soared to Record $46.2 Billion in 2015
Licensing deal values in the pharmaceutical industry rose by 37.1% year-to-year, from $33.7 billion in 2014 to $46.2 billion in 2015, driven primarily by Sanofi,…
Pharmaceutical Industry Licensing Deals Soared to Record $46.2 Billion in 2015
Licensing deal values in the pharmaceutical industry rose by 37.1% year-to-year, from $33.7 billion in 2014 to $46.2 billion in 2015, driven primarily by Sanofi,…
Pharmaceutical Companies Increasingly Looking to Innovate High-Risk, First-In-Class Products
With the cost of bringing a single novel drug to market estimated to be $2.6 billion in 2015, pharmaceutical companies are increasingly looking towards developing…
PYRAMID Laboratories Celebrates 28th Anniversary; Expands Capabilities
PYRAMID Laboratories, Inc. a premier clinical and commercial contract aseptic drug product developer and manufacturer is proud to announce it is celebrating 28 years of…
Ultragenyx & Takeda Enter Development & Commercialization Collaboration
Ultragenyx Pharmaceutical Inc. and Takeda Pharmaceutical Company Limited recently announced a strategic partnership to develop and commercialize therapies to treat rare genetic diseases. Ultragenyx will…
Enable Injections Completes Cincinnati Manufacturing Facility for On-Body Delivery Systems
Enable Injections Inc. opened its new Cincinnati manufacturing facility this month, the company announced at the BIO meeting in San Francisco. Enable Injections’ advanced On…
Cobra Biologics & Touchlight Collaborate on Production of Next-Generation DNA Constructs
Cobra Biologics Ltd and Touchlight are collaborating on a project to optimize the manufacture of Adeno-Associated Virus (AAV) vectors used in the delivery of gene…
